Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genetic Carrier Frequency for Lung Cancer

Abstract

IN a review of the evidence relating to familial aggregations of malignant disease in man it was concluded1 that these can generally be attributed to genetic factors. A similar conclusion2 has since been drawn with respect to lung cancer in man. The commonest form of predisposing inheritance appears to be a simple Mendelian dominant of incomplete penetrance, although very occasionally (but especially with parental consanguinity) apparent recessive inheritance is observed in childhood leukæmia and lymphosarcoma1. Although for a specific cancer the inherited predisposition usually affects only a single autosomal locus (perhaps one of several), the phenotypic expression in adults should generally involve somatic mutation of the gene homologous with the inherited allele, together with somatic mutation of homologous genes at another locus1,3. From twins studies4, the typical penetrance of a predisposing allele in the phenotypic form of any malignancy is calculated to be about 0.3 (ref. 1), but for a life-span of 70 years it is likely to be slightly higher than this. Cancers arising in a genetic carrier are described as ‘prezygotic’; but where there is no specific predisposition, and where all mutational events are confined to somatic cells, the resulting cancer is described as ‘postzygotic’5. It was concluded that in the absence of powerful extrinsic carcinogens, most human malignancies are probably prezygotic1. Extrinsic carcinogens should tend to change the balance in favour of postzygotic malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Burch, P. R. J., Nature, 197, 1042 (1963).

    Article  ADS  CAS  Google Scholar 

  2. Tokuhata, G. K., Amer. J. Pub. Hlth., 54, 24 (1964).

    Article  CAS  Google Scholar 

  3. Burch, P. R. J., Nature, 197, 1145 (1963).

    Article  ADS  CAS  Google Scholar 

  4. Jarvik, L. F., and Falek, A., Cancer, 15, 1009 (1962).

    Article  CAS  Google Scholar 

  5. Stewart, A., Brit. Med. J., i, 452 (1961).

  6. Tokuhata, G. K., and Lilienfeld, A. M., J. Nat. Cancer Inst., 30, 289 (1963).

    CAS  PubMed  Google Scholar 

  7. Tokuhata, G. K., and Lilienfeld, A. M., Pub. Health Rep. (Washington), 78, 277 (1963).

    Article  CAS  Google Scholar 

  8. Burch, P. R. J., Nature, 195, 241 (1962).

    Article  ADS  CAS  Google Scholar 

  9. Videbaek, A., Heredity in Human Leukœmia (Busck, Copenhagen, 1947).

    Google Scholar 

  10. Morganti, G., and Cresseri, A., Sang, 25, 421 (1954).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BURCH, P. Genetic Carrier Frequency for Lung Cancer. Nature 202, 711–712 (1964). https://doi.org/10.1038/202711a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/202711a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing